Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.
Source link
Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock
Date:
More like thisRelated
Sheryl Sandberg’s Lean In Sheds Quarter of Staff, Will Focus on Manosphere Fight
A 25-year-old has taken over as the feminist organization’s...
A knife-wielding man kills a woman at a Tokyo Pokemon shop before taking his own life
TOKYO -- A man brandishing a knife stabbed a...